Buy Abitrexate from Discount Pharmacy
We are a leading Canadian mail-order pharmacy service focusing on both on prescription cost-containment and patient safety. We only work with a small network of trusted and reputable international pharmacies and fulfillment centers, giving you access to authentic medications at low prices every day. All medications are shipped directly to you from our affiliated licensed international and Canadian pharmacies and fulfillment centers. Our staff are knowledgeable and efficient to ensure that your shopping experience is hassle free. Save on prescription drugs like Abitrexate as well as other prescription drugs like Avodart, Cialis, Crestor, Lipitor, Nexium, Norvasc, Prevacid, Seroquel, Topamax, Wellbutrin XL.
10 Great Reasons to Choose Our Service!
Live, friendly, and knowledgeable customer service helping you order your Abitrexate from a licensed pharmacy.
All Canadian prescription drugs are shipped in sealed drug manufacturer's containers from our licensed Canadian pharmacy.
Medications ordered in Canada from our Canadian pharmacy are non-taxable.
Live and professional customer service available everyday from a licensed Canadian pharmacy ready to help you order prescription drugs.
There are no duties, taxes or other fees on prescriptions drugs from our pharmacy service.
All of your drug prescriptions are reviewed by a Canadian physician and filled by a Canadian licensed pharmacists from our Canadian Pharmacy.
Our Canadian Pharmacy offers convenient payment by VISA, Master Card or international money order.
Regulated prices by the Canadian government allows Americans to buy at cheaper prices compared to US pharmacies.
Our Prescription medications are available at unbelievable discounts compared to US based pharmacies.
The international Generic Program may have the generic version of Abitrexate saving your further money.
Why Are Cancer Drugs So Expensive?
The high cost of cancer drugs is related to a number of factors. It is very very expensive to move findings from bench to bedside and to perform all the regulatory studies (from phase 1, 2, and 3 clinical trials) to gain approval. Second, even when the monopoly is broken with the arrival of 'new and improved' versions of an approved drug, the older drug (and by now generic) tends to be viewed as substandard treatment, thereby perpetuating the situation. Third, the very nature of cancer, and the seriousness of the diagnosis, plays a role in that patients and physicians are often willing to pay the high price of treatment even for marginal improvements in outcome. Finally, because most cancers are incurable, patients are treated with each approved agent creating a virtual monopoly because the use of one drug does not automatically mean that the others are no longer needed.